Annual EBIT
-$3.97 M
+$22.50 M+84.99%
December 31, 2023
Summary
- As of February 7, 2025, SBFM annual earnings before interest & taxes is -$3.97 million, with the most recent change of +$22.50 million (+84.99%) on December 31, 2023.
- During the last 3 years, SBFM annual EBIT has fallen by -$1.36 million (-51.90%).
- SBFM annual EBIT is now -30232.82% below its all-time high of -$13.10 thousand, reached on July 1, 2007.
Performance
SBFM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$982.60 K
-$144.90 K-17.30%
September 30, 2024
Summary
- As of February 7, 2025, SBFM quarterly earnings before interest & taxes is -$982.60 thousand, with the most recent change of -$144.90 thousand (-17.30%) on September 30, 2024.
- Over the past year, SBFM quarterly EBIT has dropped by -$410.60 thousand (-71.78%).
- SBFM quarterly EBIT is now -239.63% below its all-time high of $703.70 thousand, reached on December 1, 2021.
Performance
SBFM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$4.03 M
-$410.60 K-11.34%
September 30, 2024
Summary
- As of February 7, 2025, SBFM TTM earnings before interest & taxes is -$4.03 million, with the most recent change of -$410.60 thousand (-11.34%) on September 30, 2024.
- Over the past year, SBFM TTM EBIT has increased by +$22.22 million (+84.64%).
- SBFM TTM EBIT is now -45720.45% below its all-time high of -$8800.00, reached on October 1, 2007.
Performance
SBFM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SBFM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +85.0% | -71.8% | +84.6% |
| 3 y3 years | -51.9% | -21.1% | +85.1% |
| 5 y5 years | -99.2% | -21.1% | +85.1% |
SBFM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.0% | -239.6% | +95.8% | -60.3% | +85.1% |
| 5 y | 5-year | -313.0% | +85.0% | -239.6% | +95.8% | -355.1% | +85.1% |
| alltime | all time | <-9999.0% | +85.0% | -239.6% | +95.8% | <-9999.0% | +85.1% |
Sunshine Biopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$982.60 K(+17.3%) | -$4.03 M(+11.3%) |
| Jun 2024 | - | -$837.70 K(-30.9%) | -$3.62 M(+0.7%) |
| Mar 2024 | - | -$1.21 M(+21.3%) | -$3.60 M(-10.1%) |
| Dec 2023 | -$3.97 M(-85.0%) | -$999.60 K(+74.8%) | -$4.00 M(-84.8%) |
| Sep 2023 | - | -$572.00 K(-29.5%) | -$26.25 M(-3.3%) |
| Jun 2023 | - | -$811.10 K(-49.8%) | -$27.14 M(+1.0%) |
| Mar 2023 | - | -$1.62 M(-93.1%) | -$26.86 M(+1.5%) |
| Dec 2022 | -$26.47 M(+118.6%) | -$23.25 M(+1495.9%) | -$26.47 M(+952.3%) |
| Sep 2022 | - | -$1.46 M(+170.4%) | -$2.52 M(-50.2%) |
| Jun 2022 | - | -$538.90 K(-56.0%) | -$5.05 M(-29.8%) |
| Mar 2022 | - | -$1.22 M(-273.9%) | -$7.20 M(-40.6%) |
| Dec 2021 | -$12.11 M(+362.8%) | - | - |
| Dec 2021 | - | $703.70 K(-117.6%) | -$12.11 M(-12.2%) |
| Sep 2021 | - | -$3.99 M(+48.8%) | -$13.79 M(+31.7%) |
| Jun 2021 | - | -$2.68 M(-56.3%) | -$10.47 M(+20.8%) |
| Mar 2021 | - | -$6.14 M(+527.1%) | -$8.67 M(+231.6%) |
| Dec 2020 | -$2.62 M(+171.9%) | -$978.40 K(+44.6%) | -$2.62 M(+30.1%) |
| Sep 2020 | - | -$676.50 K(-23.4%) | -$2.01 M(+21.4%) |
| Jun 2020 | - | -$883.20 K(+1033.8%) | -$1.66 M(+87.0%) |
| Mar 2020 | - | -$77.90 K(-79.1%) | -$885.90 K(-7.9%) |
| Dec 2019 | -$962.20 K(-51.8%) | -$373.20 K(+15.8%) | -$962.10 K(+8.0%) |
| Sep 2019 | - | -$322.40 K(+186.8%) | -$890.60 K(-39.0%) |
| Jun 2019 | - | -$112.40 K(-27.1%) | -$1.46 M(-26.0%) |
| Mar 2019 | - | -$154.10 K(-48.9%) | -$1.97 M(-1.8%) |
| Dec 2018 | -$1.99 M(+113.2%) | -$301.70 K(-66.2%) | -$2.01 M(+8.0%) |
| Sep 2018 | - | -$892.30 K(+42.6%) | -$1.86 M(+70.9%) |
| Jun 2018 | - | -$625.70 K(+229.0%) | -$1.09 M(+16.0%) |
| Mar 2018 | - | -$190.20 K(+24.5%) | -$939.00 K(+0.4%) |
| Dec 2017 | -$935.40 K(-73.0%) | -$152.80 K(+27.1%) | -$935.40 K(-50.8%) |
| Sep 2017 | - | -$120.20 K(-74.7%) | -$1.90 M(-43.3%) |
| Jun 2017 | - | -$475.80 K(+155.0%) | -$3.35 M(+0.1%) |
| Mar 2017 | - | -$186.60 K(-83.3%) | -$3.35 M(-3.2%) |
| Dec 2016 | -$3.46 M | -$1.12 M(-28.9%) | -$3.46 M(+26.7%) |
| Sep 2016 | - | -$1.57 M(+233.9%) | -$2.73 M(+102.1%) |
| Jun 2016 | - | -$471.30 K(+58.0%) | -$1.35 M(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$298.30 K(-23.5%) | -$1.37 M(+14.6%) |
| Dec 2015 | -$1.35 M(-25.0%) | -$389.70 K(+101.8%) | -$1.19 M(+3.9%) |
| Sep 2015 | - | -$193.10 K(-60.1%) | -$1.15 M(-6.8%) |
| Jun 2015 | - | -$484.30 K(+288.1%) | -$1.23 M(-13.1%) |
| Mar 2015 | - | -$124.80 K(-63.8%) | -$1.42 M(-16.6%) |
| Dec 2014 | -$1.79 M(-27.8%) | -$344.50 K(+24.2%) | -$1.70 M(-16.7%) |
| Sep 2014 | - | -$277.40 K(-58.6%) | -$2.04 M(+5.1%) |
| Jun 2014 | - | -$670.10 K(+65.1%) | -$1.94 M(+36.4%) |
| Mar 2014 | - | -$405.90 K(-40.8%) | -$1.42 M(-42.9%) |
| Dec 2013 | -$2.48 M(+251.6%) | -$685.40 K(+285.7%) | -$2.49 M(+25.0%) |
| Sep 2013 | - | -$177.70 K(+16.4%) | -$1.99 M(-9.1%) |
| Jun 2013 | - | -$152.60 K(-89.6%) | -$2.19 M(+2.3%) |
| Mar 2013 | - | -$1.47 M(+681.6%) | -$2.14 M(+202.7%) |
| Dec 2012 | -$706.70 K(+27.1%) | -$188.30 K(-50.0%) | -$706.70 K(-20.6%) |
| Sep 2012 | - | -$376.40 K(+266.5%) | -$890.50 K(+41.2%) |
| Jun 2012 | - | -$102.70 K(+161.3%) | -$630.50 K(+15.8%) |
| Mar 2012 | - | -$39.30 K(-89.4%) | -$544.30 K(-1.8%) |
| Dec 2011 | -$556.20 K(+3.5%) | -$372.10 K(+219.7%) | -$554.20 K(-9.0%) |
| Sep 2011 | - | -$116.40 K(+605.5%) | -$609.00 K(-6.7%) |
| Jun 2011 | - | -$16.50 K(-66.5%) | -$653.00 K(-70.6%) |
| Mar 2011 | - | -$49.20 K(-88.5%) | -$2.22 M(+0.7%) |
| Dec 2010 | -$537.40 K(+437.4%) | -$426.90 K(+166.1%) | -$2.21 M(+23.9%) |
| Sep 2010 | - | -$160.40 K(-89.9%) | -$1.78 M(+7.8%) |
| Jun 2010 | - | -$1.59 M(+4489.9%) | -$1.65 M(+2204.6%) |
| Mar 2010 | - | -$34.60 K(+8.1%) | -$71.80 K(+66.6%) |
| Dec 2009 | -$100.00 K(+536.9%) | - | - |
| Oct 2009 | - | -$32.00 K(+515.4%) | -$43.10 K(+174.5%) |
| Jul 2009 | -$15.70 K(-39.8%) | -$5200.00(+108.0%) | -$15.70 K(+6.8%) |
| Apr 2009 | - | -$2500.00(-26.5%) | -$14.70 K(-36.1%) |
| Jan 2009 | - | -$3400.00(-26.1%) | -$23.00 K(+5.0%) |
| Oct 2008 | - | -$4600.00(+9.5%) | -$21.90 K(-16.1%) |
| Jul 2008 | -$26.10 K(+99.2%) | -$4200.00(-61.1%) | -$26.10 K(+19.2%) |
| Apr 2008 | - | -$10.80 K(+369.6%) | -$21.90 K(+97.3%) |
| Jan 2008 | - | -$2300.00(-73.9%) | -$11.10 K(+26.1%) |
| Oct 2007 | - | -$8800.00 | -$8800.00 |
| Jul 2007 | -$13.10 K | - | - |
FAQ
- What is Sunshine Biopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sunshine Biopharma?
- What is Sunshine Biopharma annual EBIT year-on-year change?
- What is Sunshine Biopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly EBIT year-on-year change?
- What is Sunshine Biopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Sunshine Biopharma?
- What is Sunshine Biopharma TTM EBIT year-on-year change?
What is Sunshine Biopharma annual earnings before interest & taxes?
The current annual EBIT of SBFM is -$3.97 M
What is the all time high annual EBIT for Sunshine Biopharma?
Sunshine Biopharma all-time high annual earnings before interest & taxes is -$13.10 K
What is Sunshine Biopharma annual EBIT year-on-year change?
Over the past year, SBFM annual earnings before interest & taxes has changed by +$22.50 M (+84.99%)
What is Sunshine Biopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of SBFM is -$982.60 K
What is the all time high quarterly EBIT for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly earnings before interest & taxes is $703.70 K
What is Sunshine Biopharma quarterly EBIT year-on-year change?
Over the past year, SBFM quarterly earnings before interest & taxes has changed by -$410.60 K (-71.78%)
What is Sunshine Biopharma TTM earnings before interest & taxes?
The current TTM EBIT of SBFM is -$4.03 M
What is the all time high TTM EBIT for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM earnings before interest & taxes is -$8800.00
What is Sunshine Biopharma TTM EBIT year-on-year change?
Over the past year, SBFM TTM earnings before interest & taxes has changed by +$22.22 M (+84.64%)